Report cover image

Global Colon Targeted Drug Delivery Systems Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 196 Pages
SKU # APRC20362362

Description

Summary

According to APO Research, The global Colon Targeted Drug Delivery Systems market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Colon Targeted Drug Delivery Systems is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Colon Targeted Drug Delivery Systems is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Colon Targeted Drug Delivery Systems is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Colon Targeted Drug Delivery Systems is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Colon Targeted Drug Delivery Systems include Lonza Pharma Biotech, Tillotts Pharma (Zeria Group) and Evonik Health Care, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Colon Targeted Drug Delivery Systems, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Colon Targeted Drug Delivery Systems, also provides the revenue of main regions and countries. Of the upcoming market potential for Colon Targeted Drug Delivery Systems, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Colon Targeted Drug Delivery Systems revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Colon Targeted Drug Delivery Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Colon Targeted Drug Delivery Systems revenue, projected growth trends, production technology, application and end-user industry.

Colon Targeted Drug Delivery Systems Segment by Company

Lonza Pharma Biotech
Tillotts Pharma (Zeria Group)
Evonik Health Care
Colon Targeted Drug Delivery Systems Segment by Type

Osmotic Controlled Drug Delivery (ORDS-CT)
Pressure Controlled Drug-Delivery Systems
Others
Colon Targeted Drug Delivery Systems Segment by Application

Hospital
Biology Laboratory
Other
Colon Targeted Drug Delivery Systems Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colon Targeted Drug Delivery Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Colon Targeted Drug Delivery Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colon Targeted Drug Delivery Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Colon Targeted Drug Delivery Systems in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Colon Targeted Drug Delivery Systems company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Colon Targeted Drug Delivery Systems revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Table of Contents

196 Pages
1 Market Overview
1.1 Product Definition
1.2 Colon Targeted Drug Delivery Systems Market by Type
1.2.1 Global Colon Targeted Drug Delivery Systems Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Osmotic Controlled Drug Delivery (ORDS-CT)
1.2.3 Pressure Controlled Drug-Delivery Systems
1.2.4 Others
1.3 Colon Targeted Drug Delivery Systems Market by Application
1.3.1 Global Colon Targeted Drug Delivery Systems Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Biology Laboratory
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Colon Targeted Drug Delivery Systems Market Dynamics
2.1 Colon Targeted Drug Delivery Systems Industry Trends
2.2 Colon Targeted Drug Delivery Systems Industry Drivers
2.3 Colon Targeted Drug Delivery Systems Industry Opportunities and Challenges
2.4 Colon Targeted Drug Delivery Systems Industry Restraints
3 Global Growth Perspective
3.1 Global Colon Targeted Drug Delivery Systems Market Perspective (2020-2031)
3.2 Global Colon Targeted Drug Delivery Systems Growth Trends by Region
3.2.1 Global Colon Targeted Drug Delivery Systems Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Colon Targeted Drug Delivery Systems Market Size by Region (2020-2025)
3.2.3 Global Colon Targeted Drug Delivery Systems Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Colon Targeted Drug Delivery Systems Revenue by Players
4.1.1 Global Colon Targeted Drug Delivery Systems Revenue by Players (2020-2025)
4.1.2 Global Colon Targeted Drug Delivery Systems Revenue Market Share by Players (2020-2025)
4.1.3 Global Colon Targeted Drug Delivery Systems Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Colon Targeted Drug Delivery Systems Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Colon Targeted Drug Delivery Systems Key Players Headquarters & Area Served
4.4 Global Colon Targeted Drug Delivery Systems Players, Product Type & Application
4.5 Global Colon Targeted Drug Delivery Systems Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Colon Targeted Drug Delivery Systems Market CR5 and HHI
4.6.3 2024 Colon Targeted Drug Delivery Systems Tier 1, Tier 2, and Tier 3
5 Colon Targeted Drug Delivery Systems Market Size by Type
5.1 Global Colon Targeted Drug Delivery Systems Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Colon Targeted Drug Delivery Systems Revenue by Type (2020-2031)
5.3 Global Colon Targeted Drug Delivery Systems Revenue Market Share by Type (2020-2031)
6 Colon Targeted Drug Delivery Systems Market Size by Application
6.1 Global Colon Targeted Drug Delivery Systems Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Colon Targeted Drug Delivery Systems Revenue by Application (2020-2031)
6.3 Global Colon Targeted Drug Delivery Systems Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Lonza Pharma Biotech
7.1.1 Lonza Pharma Biotech Comapny Information
7.1.2 Lonza Pharma Biotech Business Overview
7.1.3 Lonza Pharma Biotech Colon Targeted Drug Delivery Systems Revenue and Gross Margin (2020-2025)
7.1.4 Lonza Pharma Biotech Colon Targeted Drug Delivery Systems Product Portfolio
7.1.5 Lonza Pharma Biotech Recent Developments
7.2 Tillotts Pharma (Zeria Group)
7.2.1 Tillotts Pharma (Zeria Group) Comapny Information
7.2.2 Tillotts Pharma (Zeria Group) Business Overview
7.2.3 Tillotts Pharma (Zeria Group) Colon Targeted Drug Delivery Systems Revenue and Gross Margin (2020-2025)
7.2.4 Tillotts Pharma (Zeria Group) Colon Targeted Drug Delivery Systems Product Portfolio
7.2.5 Tillotts Pharma (Zeria Group) Recent Developments
7.3 Evonik Health Care
7.3.1 Evonik Health Care Comapny Information
7.3.2 Evonik Health Care Business Overview
7.3.3 Evonik Health Care Colon Targeted Drug Delivery Systems Revenue and Gross Margin (2020-2025)
7.3.4 Evonik Health Care Colon Targeted Drug Delivery Systems Product Portfolio
7.3.5 Evonik Health Care Recent Developments
8 North America
8.1 North America Colon Targeted Drug Delivery Systems Revenue (2020-2031)
8.2 North America Colon Targeted Drug Delivery Systems Revenue by Type (2020-2031)
8.2.1 North America Colon Targeted Drug Delivery Systems Revenue by Type (2020-2025)
8.2.2 North America Colon Targeted Drug Delivery Systems Revenue by Type (2026-2031)
8.3 North America Colon Targeted Drug Delivery Systems Revenue Share by Type (2020-2031)
8.4 North America Colon Targeted Drug Delivery Systems Revenue by Application (2020-2031)
8.4.1 North America Colon Targeted Drug Delivery Systems Revenue by Application (2020-2025)
8.4.2 North America Colon Targeted Drug Delivery Systems Revenue by Application (2026-2031)
8.5 North America Colon Targeted Drug Delivery Systems Revenue Share by Application (2020-2031)
8.6 North America Colon Targeted Drug Delivery Systems Revenue by Country
8.6.1 North America Colon Targeted Drug Delivery Systems Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Colon Targeted Drug Delivery Systems Revenue by Country (2020-2025)
8.6.3 North America Colon Targeted Drug Delivery Systems Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Colon Targeted Drug Delivery Systems Revenue (2020-2031)
9.2 Europe Colon Targeted Drug Delivery Systems Revenue by Type (2020-2031)
9.2.1 Europe Colon Targeted Drug Delivery Systems Revenue by Type (2020-2025)
9.2.2 Europe Colon Targeted Drug Delivery Systems Revenue by Type (2026-2031)
9.3 Europe Colon Targeted Drug Delivery Systems Revenue Share by Type (2020-2031)
9.4 Europe Colon Targeted Drug Delivery Systems Revenue by Application (2020-2031)
9.4.1 Europe Colon Targeted Drug Delivery Systems Revenue by Application (2020-2025)
9.4.2 Europe Colon Targeted Drug Delivery Systems Revenue by Application (2026-2031)
9.5 Europe Colon Targeted Drug Delivery Systems Revenue Share by Application (2020-2031)
9.6 Europe Colon Targeted Drug Delivery Systems Revenue by Country
9.6.1 Europe Colon Targeted Drug Delivery Systems Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Colon Targeted Drug Delivery Systems Revenue by Country (2020-2025)
9.6.3 Europe Colon Targeted Drug Delivery Systems Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
10 China
10.1 China Colon Targeted Drug Delivery Systems Revenue (2020-2031)
10.2 China Colon Targeted Drug Delivery Systems Revenue by Type (2020-2031)
10.2.1 China Colon Targeted Drug Delivery Systems Revenue by Type (2020-2025)
10.2.2 China Colon Targeted Drug Delivery Systems Revenue by Type (2026-2031)
10.3 China Colon Targeted Drug Delivery Systems Revenue Share by Type (2020-2031)
10.4 China Colon Targeted Drug Delivery Systems Revenue by Application (2020-2031)
10.4.1 China Colon Targeted Drug Delivery Systems Revenue by Application (2020-2025)
10.4.2 China Colon Targeted Drug Delivery Systems Revenue by Application (2026-2031)
10.5 China Colon Targeted Drug Delivery Systems Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Colon Targeted Drug Delivery Systems Revenue (2020-2031)
11.2 Asia Colon Targeted Drug Delivery Systems Revenue by Type (2020-2031)
11.2.1 Asia Colon Targeted Drug Delivery Systems Revenue by Type (2020-2025)
11.2.2 Asia Colon Targeted Drug Delivery Systems Revenue by Type (2026-2031)
11.3 Asia Colon Targeted Drug Delivery Systems Revenue Share by Type (2020-2031)
11.4 Asia Colon Targeted Drug Delivery Systems Revenue by Application (2020-2031)
11.4.1 Asia Colon Targeted Drug Delivery Systems Revenue by Application (2020-2025)
11.4.2 Asia Colon Targeted Drug Delivery Systems Revenue by Application (2026-2031)
11.5 Asia Colon Targeted Drug Delivery Systems Revenue Share by Application (2020-2031)
11.6 Asia Colon Targeted Drug Delivery Systems Revenue by Country
11.6.1 Asia Colon Targeted Drug Delivery Systems Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Colon Targeted Drug Delivery Systems Revenue by Country (2020-2025)
11.6.3 Asia Colon Targeted Drug Delivery Systems Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Colon Targeted Drug Delivery Systems Revenue (2020-2031)
12.2 SAMEA Colon Targeted Drug Delivery Systems Revenue by Type (2020-2031)
12.2.1 SAMEA Colon Targeted Drug Delivery Systems Revenue by Type (2020-2025)
12.2.2 SAMEA Colon Targeted Drug Delivery Systems Revenue by Type (2026-2031)
12.3 SAMEA Colon Targeted Drug Delivery Systems Revenue Share by Type (2020-2031)
12.4 SAMEA Colon Targeted Drug Delivery Systems Revenue by Application (2020-2031)
12.4.1 SAMEA Colon Targeted Drug Delivery Systems Revenue by Application (2020-2025)
12.4.2 SAMEA Colon Targeted Drug Delivery Systems Revenue by Application (2026-2031)
12.5 SAMEA Colon Targeted Drug Delivery Systems Revenue Share by Application (2020-2031)
12.6 SAMEA Colon Targeted Drug Delivery Systems Revenue by Country
12.6.1 SAMEA Colon Targeted Drug Delivery Systems Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Colon Targeted Drug Delivery Systems Revenue by Country (2020-2025)
12.6.3 SAMEA Colon Targeted Drug Delivery Systems Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.